Medtronic Total Debt Growth & History (MDT)
Medtronic's total debt was $27.36B for fiscal 2026.
View full Medtronic company overviewMedtronic annual total debt history
| Fiscal year | Period ended | Total debt | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-24 | $27.36B | $610.0M | +2.28% |
| 2025 | 2025-04-25 | $26.75B | $722.0M | +2.77% |
| 2024 | 2024-04-26 | $26.03B | $636.0M | +2.50% |
| 2023 | 2023-04-28 | $25.39B | $4.15B | +19.54% |
| 2022 | 2022-04-29 | $21.24B | −$6.15B | −22.45% |
| 2021 | 2021-04-30 | $27.39B | $1.48B | +5.72% |
| 2020 | 2020-04-24 | $25.91B | $505.0M | +1.99% |
| 2019 | 2019-04-26 | $25.41B | −$344.0M | −1.34% |
| 2018 | 2018-04-27 | $25.75B | −$7.64B | −22.89% |
| 2017 | 2017-04-28 | $33.39B | $2.46B | +7.94% |
| 2016 | 2016-04-29 | $30.94B | −$4.67B | −13.11% |
| 2015 | 2015-04-24 | $35.60B | $25.29B | +245.18% |
| 2014 | 2014-04-25 | $10.31B | — | — |
Medtronic quarterly total debt
| Fiscal quarter | Period ended | Total debt | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-07-31 | $25.62B | −$562.0M | −2.15% |
| Q4 2026 | 2026-04-24 | $27.36B | $610.0M | +2.28% |
| Q3 2026 | 2026-01-31 | $28.07B | $4.09B | +17.04% |
| Q3 2026 | 2026-01-23 | $27.88B | $3.90B | +16.24% |
| Q2 2026 | 2025-10-24 | $27.68B | $3.07B | +12.49% |
| Q1 2026 | 2025-07-25 | $26.18B | −$133.0M | −0.51% |
| Q4 2025 | 2025-04-25 | $26.75B | $722.0M | +2.77% |
| Q3 2025 | 2025-01-24 | $23.98B | −$168.0M | −0.70% |
| Q2 2025 | 2024-10-25 | $24.61B | $866.0M | +3.65% |
| Q1 2025 | 2024-07-26 | $26.31B | $1.85B | +7.56% |
| Q4 2024 | 2024-04-26 | $26.03B | $636.0M | +2.50% |
| Q3 2024 | 2024-01-26 | $24.15B | $1.94B | +8.75% |
| Q2 2024 | 2023-10-27 | $23.74B | $2.99B | +14.40% |
| Q1 2024 | 2023-07-28 | $24.46B | $6.98B | +39.94% |
| Q4 2023 | 2023-04-28 | $25.39B | $4.15B | +19.54% |
| Q3 2023 | 2023-01-27 | $22.21B | −$2.08B | −8.56% |
| Q2 2023 | 2022-10-28 | $20.75B | −$4.85B | −18.96% |
| Q1 2023 | 2022-07-29 | $17.48B | −$8.48B | −32.66% |
| Q4 2022 | 2022-04-29 | $21.24B | −$6.15B | −22.45% |
| Q3 2022 | 2022-01-28 | $24.29B | −$2.21B | −8.35% |
| Q2 2022 | 2021-10-29 | $25.61B | −$360.0M | −1.39% |
| Q1 2022 | 2021-07-30 | $25.96B | $3.09B | +13.52% |
| Q4 2021 | 2021-04-30 | $27.39B | $1.48B | +5.72% |
| Q3 2021 | 2021-01-29 | $26.50B | $750.0M | +2.91% |
| Q2 2021 | 2020-10-30 | $25.97B | $205.0M | +0.80% |
| Q1 2021 | 2020-07-31 | $22.87B | −$2.92B | −11.31% |
| Q4 2020 | 2020-04-24 | $25.91B | $505.0M | +1.99% |
| Q3 2020 | 2020-01-24 | $25.75B | $2.08B | +8.78% |
| Q2 2020 | 2019-10-25 | $25.76B | $2.09B | +8.82% |
| Q1 2020 | 2019-07-26 | $25.78B | $2.10B | +8.89% |
| Q4 2019 | 2019-04-26 | $25.41B | −$344.0M | −1.34% |
| Q3 2019 | 2019-01-25 | $23.67B | −$2.24B | −8.66% |
| Q2 2019 | 2018-10-26 | $23.67B | −$2.27B | −8.74% |
| Q1 2019 | 2018-07-27 | $23.68B | −$2.27B | −8.77% |
| Q4 2018 | 2018-04-27 | $25.75B | −$7.64B | −22.89% |
| Q3 2018 | 2018-01-26 | $25.92B | −$5.0M | −0.02% |
| Q2 2018 | 2017-10-27 | $25.94B | −$3.07B | −10.58% |
| Q1 2018 | 2017-07-28 | $25.95B | −$4.17B | −13.85% |
| Q4 2017 | 2017-04-28 | $33.39B | $2.46B | +7.94% |
| Q3 2017 | 2017-01-27 | $25.92B | −$7.76B | −23.03% |
| Q2 2017 | 2016-10-28 | $29.01B | −$4.68B | −13.89% |
| Q1 2017 | 2016-07-29 | $30.12B | −$3.58B | −10.64% |
| Q4 2016 | 2016-04-29 | $30.94B | −$4.67B | −13.11% |
| Q3 2016 | 2016-01-29 | $33.68B | — | — |
| Q2 2016 | 2015-10-30 | $33.69B | — | — |
| Q1 2016 | 2015-07-31 | $33.71B | — | — |
| Q4 2015 | 2015-04-24 | $35.60B | $25.29B | +245.18% |
| Q4 2014 | 2014-04-25 | $10.31B | — | — |
Medtronic total debt trends
Over the last five fiscal years, Medtronic's total debt decreased from $27.39B to $27.36B, a change of −$32.0M. The latest reported quarter, Q1 2027, shows $25.62B.
What total debt means
Total debt measures a company’s reported interest-bearing borrowing obligations at a reporting-period end. It can include short-term borrowings, current maturities, long-term debt, and finance lease obligations when they are included in the company’s debt facts.
SEC-reported and combined total debt
TickerStat uses a reported aggregate debt value when available. Otherwise, it combines non-overlapping current and noncurrent debt facts from SEC filings. Total liabilities are not treated as debt, and missing debt is not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medtronic source filings ↗Community posts
Medtronic begins European clinical use of its Stealth AXiS surgical system
Medtronic ($MDT) announced the first European procedures using its Stealth AXiS surgical system, with more than 23 procedures performed across seven sites in Germany, the UK, Italy and Spain. The initial experience includes spinal surgery. ...